At a glance
- Originator PharmaMar
- Class Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 08 Aug 2003 Discontinued - Preclinical for HIV-1 infections in Spain (unspecified route)
- 07 Oct 1999 Preclinical development for HIV-1 infections in Spain (Unknown route)
- 31 Jul 1998 No-Development-Reported for HIV-1 infections in Spain (Unknown route)